Literature DB >> 2860900

The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes.

E Schön, H W Mansfeld, H U Demuth, A Barth, S Ansorge.   

Abstract

Dipeptidyl peptidase IV can be demonstrated in 60% of T lymphocytes from human peripheral blood. As could be shown recently, this enzyme is irreversibly inhibited by N-Ala-Pro-O-(nitrobenzoyl-)hydroxylamine, a substrate analogous enzyme-activated inhibitor of X-Pro-specific peptidases. We found that this inhibitor was able to suppress the proliferation of human lymphocytes stimulated with mitogens or allogeneic cells. Furthermore, after stimulation with pokeweed mitogen the development of lymphocytes containing cytoplasmic immunoglobulins and thiol proteindisulfide oxidoreductase was reduced in the presence of this inhibitor. It is concluded that dipeptidyl peptidase IV is involved or might represent a limiting factor in the process of regulation of T lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860900

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  6 in total

1.  Effects of linagliptin on human immortalized podocytes: a cellular system to study dipeptidyl-peptidase 4 inhibition.

Authors:  Gianluca Miglio; Giovanna Vitarelli; Thomas Klein; Elisa Benetti
Journal:  Br J Pharmacol       Date:  2017-03-06       Impact factor: 8.739

2.  The importance of protease histochemistry in pathology.

Authors:  Z Lojda
Journal:  Histochem J       Date:  1985-10

3.  Inhibition of dipeptidyl peptidase IV by fluoroolefin-containing N-peptidyl-O-hydroxylamine peptidomimetics.

Authors:  J Lin; P J Toscano; J T Welch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

4.  CD26/dipeptidyl peptidase IV (CD26/DPPIV) is highly expressed in peripheral blood of HIV-1 exposed uninfected female sex workers.

Authors:  Elijah M Songok; Bernard Osero; Lyle McKinnon; Martin K Rono; Winnie Apidi; Elizabeth J Matey; Adrienne F A Meyers; Ma Luo; Joshua Kimani; Charles Wachihi; Blake T Ball; Frank A Plummer; Solomon Mpoke
Journal:  Virol J       Date:  2010-11-25       Impact factor: 4.099

Review 5.  CD26 and Asthma: a Comprehensive Review.

Authors:  Juan J Nieto-Fontarigo; Francisco J González-Barcala; Esther San José; Pilar Arias; Montserrat Nogueira; Francisco J Salgado
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

6.  Inhibition of Podocytes DPP4 Activity Is a Potential Mechanism of Lobeliae Chinensis Herba in Treating Diabetic Kidney Disease.

Authors:  Xinyu Wang; Jiaqing Xiang; Guixiao Huang; Lin Kang; Guangyan Yang; Han Wu; Kewei Jiang; Zhen Liang; Shu Yang
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.